PE  Curewell Capital

https://www.curewellcapital.com/





     Office Locations:

11601 Wilshire Blvd., Suite 420
Los Angeles, CA 90025
Phone: 310-361-1510

 

Stages:

  • Middle Market


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Curewell Capital is a growth-oriented investment firm focused exclusively on building industry-leading healthcare companies. Curewell Capital partners with owners and management teams leading extraordinary companies that improve patient outcomes, create efficiencies and foster innovation. Curewell Capital's patient capital base provides the ability to invest in minority and majority equity positions with a flexible time horizon. Curewell is focused on healthcare services, pharmaceutical services, medical devices, and healthcare technology.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Adam Narwicz Vice President
    Apurva Srivastav Vice President
    Ceron Rhee Partner
    Michael Dal Bello Partner

     

    Portfolio companies include:


      Alliance for Multispecialty Research


      Clinical Innovations


      KabaFusion


      WeInfuse


     

    Recent News: